FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407128008: Abarelix (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2150958016 Abarelix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158739015 Abarelix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2150958016 Abarelix (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2150958016 Abarelix (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158739015 Abarelix en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2158739015 Abarelix en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
788491000172110 abarélix fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
788491000172110 abarélix fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Abarelix Is a Gonadotropin releasing hormone receptor antagonist true Inferred relationship Existential restriction modifier (core metadata concept)
Abarelix Has disposition Gonadotropin releasing hormone receptor antagonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Abarelix Is a Polypeptide true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Abarelix-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abarelix Inferred relationship Existential restriction modifier (core metadata concept) 1
Plenaxis The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abarelix Inferred relationship Existential restriction modifier (core metadata concept)
Abarelix 100mg powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abarelix Inferred relationship Existential restriction modifier (core metadata concept)
Plenaxis 100mg powder for injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Abarelix Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only abarelix (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Abarelix Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start